Report cover image

Global Personalized Radioimmunotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 199 Pages
SKU # APRC20278153

Description

Summary

According to APO Research, The global Personalized Radioimmunotherapy market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Personalized Radioimmunotherapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Personalized Radioimmunotherapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Personalized Radioimmunotherapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Personalized Radioimmunotherapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Personalized Radioimmunotherapy include Novartis, Bayer, Y-mAbs Therapeutics, Telix Pharmaceuticals, RadioMedix, Philogen, Orano Med, Nordic Nanovector and Mundipharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Personalized Radioimmunotherapy, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Personalized Radioimmunotherapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Personalized Radioimmunotherapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Personalized Radioimmunotherapy revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Personalized Radioimmunotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Personalized Radioimmunotherapy revenue, projected growth trends, production technology, application and end-user industry.

Personalized Radioimmunotherapy Segment by Company

Novartis
Bayer
Y-mAbs Therapeutics
Telix Pharmaceuticals
RadioMedix
Philogen
Orano Med
Nordic Nanovector
Mundipharma
Lantheus
Gilead Sciences
Fusion Pharmaceuticals
Curium Pharmaceuticals
Curasight
Clarity Pharmaceuticals
China Isotope & Radiation
Aurobindo Pharma
Actinium Pharmaceuticals
Personalized Radioimmunotherapy Segment by Type

Beta-emitting
Targeted Alpha Therapy
Personalized Radioimmunotherapy Segment by Application

Solid Tumor
Non Hodgkin Lymphoma
Personalized Radioimmunotherapy Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Radioimmunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Personalized Radioimmunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Radioimmunotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Personalized Radioimmunotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personalized Radioimmunotherapy industry.
Chapter 3: Detailed analysis of Personalized Radioimmunotherapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Radioimmunotherapyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Personalized Radioimmunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Beta-emitting
1.2.3 Targeted Alpha Therapy
1.3 Market Analysis by Application
1.3.1 Global Personalized Radioimmunotherapy Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Solid Tumor
1.3.3 Non Hodgkin Lymphoma
1.4 Global Market Growth Prospects
1.5 Global Personalized Radioimmunotherapy Growth Trends by Region
1.5.1 Global Personalized Radioimmunotherapy Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Personalized Radioimmunotherapy Market Size by Region (2020-2025)
1.5.3 Personalized Radioimmunotherapy Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Personalized Radioimmunotherapy Market Dynamics
2.1 Personalized Radioimmunotherapy Industry Trends
2.2 Personalized Radioimmunotherapy Industry Drivers
2.3 Personalized Radioimmunotherapy Industry Opportunities and Challenges
2.4 Personalized Radioimmunotherapy Industry Restraints
3 Competitive Landscape by Company
3.1 Global Personalized Radioimmunotherapy Revenue by Company (2020-2025)
3.2 Global Personalized Radioimmunotherapy Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Personalized Radioimmunotherapy Key Company Head office and Area Served
3.4 Global Personalized Radioimmunotherapy Company, Product Type & Application
3.5 Global Personalized Radioimmunotherapy Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Personalized Radioimmunotherapy Market CR5 and HHI
3.6.2 Global Top 5 and 10 Personalized Radioimmunotherapy Players Market Share by Revenue in 2024
3.6.3 2024 Personalized Radioimmunotherapy Tier 1, Tier 2, and Tier 3
4 Personalized Radioimmunotherapy Market by Type
4.1 Global Personalized Radioimmunotherapy Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Personalized Radioimmunotherapy Market Size by Type (2020-2031)
4.3 Global Personalized Radioimmunotherapy Market Size Share by Type (2020-2031)
5 Personalized Radioimmunotherapy Market by Application
5.1 Global Personalized Radioimmunotherapy Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Personalized Radioimmunotherapy Market Size by Application (2020-2031)
5.3 Global Personalized Radioimmunotherapy Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Novartis
6.1.1 Novartis Comapny Information
6.1.2 Novartis Business Overview
6.1.3 Novartis Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Novartis Personalized Radioimmunotherapy Product Portfolio
6.1.5 Novartis Recent Developments
6.2 Bayer
6.2.1 Bayer Comapny Information
6.2.2 Bayer Business Overview
6.2.3 Bayer Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Bayer Personalized Radioimmunotherapy Product Portfolio
6.2.5 Bayer Recent Developments
6.3 Y-mAbs Therapeutics
6.3.1 Y-mAbs Therapeutics Comapny Information
6.3.2 Y-mAbs Therapeutics Business Overview
6.3.3 Y-mAbs Therapeutics Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Y-mAbs Therapeutics Personalized Radioimmunotherapy Product Portfolio
6.3.5 Y-mAbs Therapeutics Recent Developments
6.4 Telix Pharmaceuticals
6.4.1 Telix Pharmaceuticals Comapny Information
6.4.2 Telix Pharmaceuticals Business Overview
6.4.3 Telix Pharmaceuticals Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Telix Pharmaceuticals Personalized Radioimmunotherapy Product Portfolio
6.4.5 Telix Pharmaceuticals Recent Developments
6.5 RadioMedix
6.5.1 RadioMedix Comapny Information
6.5.2 RadioMedix Business Overview
6.5.3 RadioMedix Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 RadioMedix Personalized Radioimmunotherapy Product Portfolio
6.5.5 RadioMedix Recent Developments
6.6 Philogen
6.6.1 Philogen Comapny Information
6.6.2 Philogen Business Overview
6.6.3 Philogen Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Philogen Personalized Radioimmunotherapy Product Portfolio
6.6.5 Philogen Recent Developments
6.7 Orano Med
6.7.1 Orano Med Comapny Information
6.7.2 Orano Med Business Overview
6.7.3 Orano Med Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 Orano Med Personalized Radioimmunotherapy Product Portfolio
6.7.5 Orano Med Recent Developments
6.8 Nordic Nanovector
6.8.1 Nordic Nanovector Comapny Information
6.8.2 Nordic Nanovector Business Overview
6.8.3 Nordic Nanovector Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Nordic Nanovector Personalized Radioimmunotherapy Product Portfolio
6.8.5 Nordic Nanovector Recent Developments
6.9 Mundipharma
6.9.1 Mundipharma Comapny Information
6.9.2 Mundipharma Business Overview
6.9.3 Mundipharma Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Mundipharma Personalized Radioimmunotherapy Product Portfolio
6.9.5 Mundipharma Recent Developments
6.10 Lantheus
6.10.1 Lantheus Comapny Information
6.10.2 Lantheus Business Overview
6.10.3 Lantheus Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 Lantheus Personalized Radioimmunotherapy Product Portfolio
6.10.5 Lantheus Recent Developments
6.11 Gilead Sciences
6.11.1 Gilead Sciences Comapny Information
6.11.2 Gilead Sciences Business Overview
6.11.3 Gilead Sciences Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.11.4 Gilead Sciences Personalized Radioimmunotherapy Product Portfolio
6.11.5 Gilead Sciences Recent Developments
6.12 Fusion Pharmaceuticals
6.12.1 Fusion Pharmaceuticals Comapny Information
6.12.2 Fusion Pharmaceuticals Business Overview
6.12.3 Fusion Pharmaceuticals Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.12.4 Fusion Pharmaceuticals Personalized Radioimmunotherapy Product Portfolio
6.12.5 Fusion Pharmaceuticals Recent Developments
6.13 Curium Pharmaceuticals
6.13.1 Curium Pharmaceuticals Comapny Information
6.13.2 Curium Pharmaceuticals Business Overview
6.13.3 Curium Pharmaceuticals Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.13.4 Curium Pharmaceuticals Personalized Radioimmunotherapy Product Portfolio
6.13.5 Curium Pharmaceuticals Recent Developments
6.14 Curasight
6.14.1 Curasight Comapny Information
6.14.2 Curasight Business Overview
6.14.3 Curasight Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.14.4 Curasight Personalized Radioimmunotherapy Product Portfolio
6.14.5 Curasight Recent Developments
6.15 Clarity Pharmaceuticals
6.15.1 Clarity Pharmaceuticals Comapny Information
6.15.2 Clarity Pharmaceuticals Business Overview
6.15.3 Clarity Pharmaceuticals Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.15.4 Clarity Pharmaceuticals Personalized Radioimmunotherapy Product Portfolio
6.15.5 Clarity Pharmaceuticals Recent Developments
6.16 China Isotope & Radiation
6.16.1 China Isotope & Radiation Comapny Information
6.16.2 China Isotope & Radiation Business Overview
6.16.3 China Isotope & Radiation Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.16.4 China Isotope & Radiation Personalized Radioimmunotherapy Product Portfolio
6.16.5 China Isotope & Radiation Recent Developments
6.17 Aurobindo Pharma
6.17.1 Aurobindo Pharma Comapny Information
6.17.2 Aurobindo Pharma Business Overview
6.17.3 Aurobindo Pharma Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.17.4 Aurobindo Pharma Personalized Radioimmunotherapy Product Portfolio
6.17.5 Aurobindo Pharma Recent Developments
6.18 Actinium Pharmaceuticals
6.18.1 Actinium Pharmaceuticals Comapny Information
6.18.2 Actinium Pharmaceuticals Business Overview
6.18.3 Actinium Pharmaceuticals Personalized Radioimmunotherapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.18.4 Actinium Pharmaceuticals Personalized Radioimmunotherapy Product Portfolio
6.18.5 Actinium Pharmaceuticals Recent Developments
7 North America
7.1 North America Personalized Radioimmunotherapy Market Size (2020-2031)
7.2 North America Personalized Radioimmunotherapy Market Size by Type
7.2.1 North America Personalized Radioimmunotherapy Market Size by Type (2020-2025)
7.2.2 North America Personalized Radioimmunotherapy Market Size by Type (2026-2031)
7.2.3 North America Personalized Radioimmunotherapy Market Share by Type (2020-2031)
7.3 North America Personalized Radioimmunotherapy Market Size by Application
7.3.1 North America Personalized Radioimmunotherapy Market Size by Application (2020-2025)
7.3.2 North America Personalized Radioimmunotherapy Market Size by Application (2026-2031)
7.3.3 North America Personalized Radioimmunotherapy Market Share by Application (2020-2031)
7.4 North America Personalized Radioimmunotherapy Market Size by Country
7.4.1 North America Personalized Radioimmunotherapy Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Personalized Radioimmunotherapy Market Size by Country (2020-2025)
7.4.3 North America Personalized Radioimmunotherapy Market Size by Country (2026-2031)
7.4.4 North America Personalized Radioimmunotherapy Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Personalized Radioimmunotherapy Market Size (2020-2031)
8.2 Europe Personalized Radioimmunotherapy Market Size by Type
8.2.1 Europe Personalized Radioimmunotherapy Market Size by Type (2020-2025)
8.2.2 Europe Personalized Radioimmunotherapy Market Size by Type (2026-2031)
8.2.3 Europe Personalized Radioimmunotherapy Market Share by Type (2020-2031)
8.3 Europe Personalized Radioimmunotherapy Market Size by Application
8.3.1 Europe Personalized Radioimmunotherapy Market Size by Application (2020-2025)
8.3.2 Europe Personalized Radioimmunotherapy Market Size by Application (2026-2031)
8.3.3 Europe Personalized Radioimmunotherapy Market Share by Application (2020-2031)
8.4 Europe Personalized Radioimmunotherapy Market Size by Country
8.4.1 Europe Personalized Radioimmunotherapy Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Personalized Radioimmunotherapy Market Size by Country (2020-2025)
8.4.3 Europe Personalized Radioimmunotherapy Market Size by Country (2026-2031)
8.4.4 Europe Personalized Radioimmunotherapy Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Personalized Radioimmunotherapy Market Size (2020-2031)
9.2 China Personalized Radioimmunotherapy Market Size by Type
9.2.1 China Personalized Radioimmunotherapy Market Size by Type (2020-2025)
9.2.2 China Personalized Radioimmunotherapy Market Size by Type (2026-2031)
9.2.3 China Personalized Radioimmunotherapy Market Share by Type (2020-2031)
9.3 China Personalized Radioimmunotherapy Market Size by Application
9.3.1 China Personalized Radioimmunotherapy Market Size by Application (2020-2025)
9.3.2 China Personalized Radioimmunotherapy Market Size by Application (2026-2031)
9.3.3 China Personalized Radioimmunotherapy Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Personalized Radioimmunotherapy Market Size (2020-2031)
10.2 Asia Personalized Radioimmunotherapy Market Size by Type
10.2.1 Asia Personalized Radioimmunotherapy Market Size by Type (2020-2025)
10.2.2 Asia Personalized Radioimmunotherapy Market Size by Type (2026-2031)
10.2.3 Asia Personalized Radioimmunotherapy Market Share by Type (2020-2031)
10.3 Asia Personalized Radioimmunotherapy Market Size by Application
10.3.1 Asia Personalized Radioimmunotherapy Market Size by Application (2020-2025)
10.3.2 Asia Personalized Radioimmunotherapy Market Size by Application (2026-2031)
10.3.3 Asia Personalized Radioimmunotherapy Market Share by Application (2020-2031)
10.4 Asia Personalized Radioimmunotherapy Market Size by Country
10.4.1 Asia Personalized Radioimmunotherapy Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Personalized Radioimmunotherapy Market Size by Country (2020-2025)
10.4.3 Asia Personalized Radioimmunotherapy Market Size by Country (2026-2031)
10.4.4 Asia Personalized Radioimmunotherapy Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size (2020-2031)
11.2 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Type
11.2.1 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Personalized Radioimmunotherapy Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Application
11.3.1 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Personalized Radioimmunotherapy Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Country
11.4.1 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Personalized Radioimmunotherapy Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Personalized Radioimmunotherapy Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.